Pre-market · Regular session opens 9:30 AM ET
Last update: Jun 30, 2026, 3:54 AM ET

Cerebras Systems Inc. (CBRS) — What Changed

$216.16+34.57 (+19.04%) vs yesterday's close
Jun 30, 2026 6:13 AM ET·NASDAQ Global Market·Pre-market·CEO: Andrew D. Feldman·340 employees

Cerebras Systems Inc. is a leading innovator in artificial intelligence infrastructure. The company develops and manufactures an advanced AI compute platform, integrating proprietary hardware systems

🔔Major Change Detected
Market Cap
$48.2B
Sector
Technology
Semiconductors
Next Earnings
Aug 10, 2026
(42 Days)
Relative Volume
1.51x
Above Avg
Risk Level
Low
Price Move
+19.04%
1-Day Change
Above 5D Avg: +8.0%
Volume Confirmation
1.51x
vs 30D Average
Above Average Volume
Catalyst
Earnings Beat
Material / Earnings
Cellular Biomedicine Group (CBRS) reported EPS of -$0.04 versus the consensus…
Peer Context
In Line With Peers
No peer data
Company-Specific Move
Signal Quality
High
Confidence Score
83/100

BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.

1Event Reaction Chart
Price reaction around a key event
CBRSCerebras Systems Inc.$216.16+34.57 (+19.04%)
168.18182.93197.68212.43227.17Price (USD)Jun 23Jun 24Jun 25Jun 26Jun 29216.16
Earnings Beat·Jun 23, 2026·+1.02% reaction

1. What Changed Since Last Close

V
Price Move UpHighHigh
Jun 29+19.04%1.03x vol

Cerebras Systems Inc. (CBRS) moved +19.04% from $181.59 to $216.16 on 2026-06-29. We checked news, earnings, analyst upd

F
New FilingHighHigh
Jun 24-19.61%1.67x vol

Cellebrite DI Ltd. (CBRS) filed its 10-Q quarterly report on 2026-06-24 with no measurable price movement on the filing

E
Earnings BeatHighHigh
Jun 23+1.02%0.65x vol

Cellular Biomedicine Group (CBRS) reported EPS of -$0.04 versus the consensus estimate of -$0.16, a 75.6% positive surpr

Showing 3 of 3 events

2. Change Timeline

DateChangePrice Reaction Volume Confidence
Jun 23
EEarnings Beat
+1.02%0.65xHigh
Jun 29
VPrice Move Up
+19.04%1.03xHigh
Jun 24
FNew Filing
-19.61%1.67xHigh
Sort:  

3. Why It Moved

1
Primary Catalyst
Earnings Beat
Cellular Biomedicine Group (CBRS) reported EPS of -$0.04 versus the consensus es
2
Supporting Evidence
  • Cellular Biomedicine Group (CBRS) reported EPS of -$0.04 versus the co
  • Cerebras Systems Inc. (CBRS) moved +19.04% from $181.59 to $216.16 on
3
Nature of Move
Company-Specific Move
CBRS outperformed peers by more than expected sector variance — move appears company-specific.

4. Peer / Sector Confirmation

SymbolToday5DRel. Vol
CBRS+19.04%1.51x
Company-Specific Move. No peer data. CBRS outperformed peers by more than expected sector variance — move appears company-specific.

5. SEC Filing Watch

Jun 24Medium
Quarterly financial results
Jun 23High
Material event — review for impact
May 15High
Material event — review for impact
Apr 17High
Securities registration
View on SEC EDGAR →Source: filing_snapshots DB · past 120 days

6. Analyst Expectations

Consensus Target
$297.25
Median Target
$300.00
Upside to Target
+37.5%
vs $216.16
Analyst Activity — Last 90 Days
0
Upgrades
5
Maintains
0
Downgrades
Last Directional Actions
No upgrades found in history
No downgrades found in history

7. Bull vs Bear Thesis Shift

Bullish Factors
Earnings beat with positive market reaction
Strong 19.0% price move with conviction
Cerebras Systems Inc. (CBRS) moved +19.04% from $181.59 to $
Bearish Factors
New SEC filing — review for material disclosures
Net Thesis Change vs Yesterday
BearishNeutralBullish
Bullish Shift+45 / 100

8. What To Watch Next

DateEventImpact
Aug 11Earnings ReleaseHigh
Sep 22Earnings ReleaseHigh
Sep 23est.10-Q FilingMedium
est. = estimated from prior filing cycle
🔔
9. Set Alerts & Get Notified
Get notified when CBRS reports earnings, files an 8-K, receives an analyst upgrade, or sees unusual volume.
Earnings alerts
Filing alerts
Volume spikes
Analyst actions

Educational research tool — not personalized investment advice. Data may be delayed.